| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
471,098,000 | 402,836,000 | 350,018,000 | 307,394,000 | 282,836,000 |
|
Cost of Revenue
|
-184,400,000 | -162,535,000 | -146,306,000 | -133,332,000 | -126,203,000 |
|
Gross Profit
|
286,698,000 | 240,301,000 | 203,712,000 | 174,062,000 | 156,633,000 |
| Selling, General and Administrative Expenses
|
-55,259,000 | -50,175,000 | -41,996,000 | -44,342,000 | -42,291,000 |
|
Research and Development Expenses
|
-74,463,000 | -61,087,000 | -49,326,000 | -45,427,000 | -39,500,000 |
|
Operating Income/Expenses
|
-129,722,000 | -111,262,000 | -91,322,000 | -89,769,000 | -81,791,000 |
|
Total Operating Profit/Loss
|
156,976,000 | 129,039,000 | 112,390,000 | 84,293,000 | 74,842,000 |
| Total Net Finance Income/Expense
|
2,712,000 | 3,601,000 | 4,214,000 | 3,557,000 | 1,817,000 |
| Net Investment Income
|
128,848,000 | 24,519,000 | 2,074,000 | -2,689,000 | -6,510,000 |
|
Other Income/Expense, Non-Operating
|
-899,000 | 1,667,000 | 1,137,000 | 556,000 | 1,179,000 |
|
Non-Operating Income/Expenses, Total
|
130,661,000 | 29,787,000 | 7,425,000 | 1,424,000 | -3,514,000 |
|
Pretax Income
|
287,637,000 | 158,826,000 | 119,815,000 | 85,717,000 | 71,328,000 |
|
Provision for Income Tax
|
-51,943,000 | -26,656,000 | -19,697,000 | -11,922,000 | -11,356,000 |
|
Net Income from Continuing Operations
|
235,694,000 | 132,170,000 | 100,118,000 | 73,795,000 | 59,972,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
235,694,000 | 132,170,000 | 100,118,000 | 73,795,000 | 59,972,000 |
|
Net Income after Non-Controlling/Minority Interests
|
235,694,000 | 132,170,000 | 100,118,000 | 73,795,000 | 59,972,000 |
| Preferred/Other Stock Distribution
|
-384,000 | -- | -- | -- | -- |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-86,000 | -- | -- | -- | -- |
|
Net Income Available to Common Stockholders
|
235,310,000 | 132,170,000 | 100,118,000 | 73,795,000 | 59,972,000 |
|
Dilution to Earnings
|
0 | -- | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
235,310,000 | 132,170,000 | 100,118,000 | 73,795,000 | 59,972,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
284,925,000 | 155,225,000 | 115,601,000 | 82,160,000 | 69,511,000 |
|
EBITDA
|
312,920,000 | 176,361,000 | 130,912,000 | 94,106,000 | 82,986,000 |
|
Normalized EBITDA
|
214,220,000 | 176,694,000 | 151,026,000 | 117,389,000 | 107,867,000 |
|
Normalized Income
|
154,817,739.50 | 132,447,056 | 116,933,304 | 93,841,663 | 80,896,921 |
|
Total Unusual Items
|
-98,700,000 | 333,000 | 20,114,000 | 23,283,000 | 24,881,000 |
|
Total Unusual Items Excluding Goodwill
|
-98,700,000 | 333,000 | 20,114,000 | 23,283,000 | 24,881,000 |
|
Tax Effect of Unusual Items
|
-17,823,739.50 | 55,944 | 3,298,696 | 3,236,337 | 3,956,079 |
|
Tax Rate, Calculated
|
0.18 | 0.17 | 0.16 | 0.14 | 0.16 |
12/31/2022 - 6/3/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade